Location of Repository

T-Cell Promiscuity in Autoimmune Diabetes

By Li Li, Bo Wang, Jeffrey A. Frelinger and Roland Tisch


OBJECTIVE—It is well established that the primary mediators of β-cell destruction in type 1 diabetes are T-cells. Nevertheless, the molecular basis for recognition of β-cell–specific epitopes by pathogenic T-cells remains ill defined; we seek to further explore this issue

Topics: Immunology and Transplantation
Publisher: American Diabetes Association
OAI identifier: oai:pubmedcentral.nih.gov:2494676
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (2001). A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
    2. (2001). Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2:797–801,
    3. (2003). B: CDR3 loop flexibility contributes to the degeneracy of TCR recognition.
    4. (2007). BM: Structures of MART-126/27–35 peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.
    5. (2000). Catching heart disease”: antigenic mimicry and bacterial infections. Nat Med 6:841–842,
    6. (2006). cross-reactive epitope specificities of CD8 T cell responses are induced by natural hepatitis B surface antigen variants of different hepatitis B virus genotypes.
    7. (2001). DB: Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.
    8. (2005). Defective central tolerance induction in NOD mice: genomics and genetics. Immunity 22:385–396,
    9. (2000). DH: Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 12:699–710,
    10. (1998). Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity 8:571– 580,
    11. (2004). DiLorenzo TP: Individual nonobese diabetic mice exhibit unique patterns of CD8 T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase.
    12. (2001). DL: The frequency of high avidity T cells determines the hierarchy of determinant spreading.
    13. (2003). DM: TCRs with high affinity for foreign pMHC show self-reactivity. Nat Immunol 4:55–62,
    14. (1998). Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in nonobese diabetic mice. Immunol Rev 164:111–118,
    15. (2002). Erlich HA: The HLA class I A locus affects susceptibility to type 1 diabetes. Hum Immunol 63:657–664,
    16. (1999). Fathman CG: A new look at MHC and autoimmune disease. Science 284:749–751,
    17. (2002). Fugger L: A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 3:940–943,
    18. (2005). GS: Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
    19. (2002). H: CD4() T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.
    20. (1998). IA: Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279:1166–1172,
    21. (1994). Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516–542,
    22. Insulin-dependent diabetes mellitus.
    23. (1994). Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice.
    24. (2004). JW: Mimotopes for alloreactive and conventional T cells in a peptide-MHC display library. PLoS Biol 2:E90,
    25. (2005). KC: Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity 22:81–92,
    26. (1991). Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell 66:533–540,
    27. (1988). LS: Both the Lyt-2 and L3T4 T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.
    28. (1996). Marrack P: The repertoire of T cells shaped by a single MHC/peptide ligand. Cell 84:521–529,
    29. (1993). McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
    30. MM: A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10:485–492,
    31. (2003). MM: Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation.
    32. (1998). Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279:1344–1347,
    33. (1998). Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology.
    34. (1999). Prevalent CD8() T cell response against one peptide/MHC complex in autoimmune diabetes. Proc Natl Acad Sci 96:9311–9316,
    35. (2000). Progression of autoimmune diabetes driven by avidity maturation of a T-cell population.
    36. (1993). PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.
    37. (2001). Roep BO: Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci 98:3988– 3991,
    38. (2001). Selin LK: Memory CD8 T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2:1067–1076,
    39. (2002). Selin LK: T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol 3:627–634,
    40. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates: requirement for both L3T4 and Lyt-2 T cells.
    41. (2004). T cell receptor crossreactivity as a general property of T cell recognition. Mol Immunol 40:1009–1017,
    42. (2005). The cellular mechanism of Aire control of T cell tolerance. Immunity 23:227– 239,
    43. (1997). The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727–738,
    44. (1986). Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35:855– 860,
    45. (1999). Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes.
    46. (1994). Tuomilehto-Wolf E: A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia 37:937–944,
    47. (2008). Unanue ER: The class II MHC L.
    48. (2002). Vignali DAA: Reliable generation and use of MHC class II:g2aFc multimers for the identification of antigenspecific CD4 T cells.
    49. Wucherpfennig KW: pH-dependent peptide binding properties of the type I diabetes-associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.